Literature DB >> 16081866

Is prehypertension a risk factor for cardiovascular diseases?

Adnan I Qureshi1, M Fareed K Suri, Jawad F Kirmani, Afshin A Divani, Yousef Mohammad.   

Abstract

BACKGROUND AND
PURPOSE: The Joint National Committee on High Blood Pressure identified a new category of blood pressure in adults termed prehypertension. Our objective was to determine the long-term risk of cardiovascular diseases associated with this new category in a well-defined cohort of adults.
METHODS: We evaluated the association of prehypertension (120 to 139/80 to 89 mm Hg) and hypertension (>140/90 mm Hg) with the incidence of atherothrombotic brain infarction (ABI), all strokes, myocardial infarction (MI), and coronary artery disease (CAD) using pooled repeated measures and Cox proportional hazards analyses during follow-up after adjusting for age, gender, obesity, diabetes mellitus, hypercholesterolemia, cigarette smoking, and study period in a cohort of 5181 persons who participated in the Framingham Study.
RESULTS: Among the 11,116 person observations with a mean follow-up period of 9.9+/-1.0 years, prehypertension was not associated with an increased risk for ABI (relative risk [RR], 2.2; 95% CI, 0.5 to 9.3). Among the 11,802 person observations with a mean follow-up period of 9.7+/-1.5 years, prehypertension was associated with an increased risk for MI (RR, 3.5; 95% CI, 1.6 to 7.5). Prehypertension was also associated with an increased risk of CADs among the 11,570 person observations (RR, 1.7; 95% CI, 1.2 to 2.4).
CONCLUSIONS: Prehypertension appears to be associated with an increased risk of MI and CAD but not stroke. Further studies are required to confirm the anticipated benefits of identifying and intervening in persons with prehypertension.

Entities:  

Mesh:

Year:  2005        PMID: 16081866     DOI: 10.1161/01.STR.0000177495.45580.f1

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  76 in total

1.  Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure.

Authors:  Antonio Ruvolo; Valentina Mercurio; Valeria Fazio; Guido Carlomagno; Teresa Russo; Flora Affuso; Serafino Fazio
Journal:  World J Cardiol       Date:  2010-05-26

2.  Presence of baseline prehypertension and risk of incident stroke: a meta-analysis.

Authors:  M Lee; J L Saver; B Chang; K-H Chang; Q Hao; B Ovbiagele
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

3.  Elevated serum retinol-binding protein 4 levels are correlated with blood pressure in prehypertensive Chinese.

Authors:  J-X Zhang; G-P Zhu; B-L Zhang; Y-Y Cheng
Journal:  J Hum Hypertens       Date:  2017-06-22       Impact factor: 3.012

4.  Prehypertension: detection, evaluation, and management.

Authors:  Ross Pacini; Dhaval R Patel; Venkata Bavikati; Laurence S Sperling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

Review 5.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

6.  Prehypertension and hypertension in a primary care practice.

Authors:  Marshall Godwin; Andrea Pike; Allison Kirby; Carolyn Jewer; Laura Murphy
Journal:  Can Fam Physician       Date:  2008-10       Impact factor: 3.275

7.  Prehypertension and endothelial progenitor cell function.

Authors:  O J MacEneaney; C A DeSouza; B R Weil; E J Kushner; G P Van Guilder; M L Mestek; J J Greiner; B L Stauffer
Journal:  J Hum Hypertens       Date:  2010-03-25       Impact factor: 3.012

Review 8.  Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.

Authors:  Xiaofan Guo; Xiaoyu Zhang; Liang Guo; Zhao Li; Liqiang Zheng; Shasha Yu; Hongmei Yang; Xinghu Zhou; Xingang Zhang; Zhaoqing Sun; Jue Li; Yingxian Sun
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

9.  Is prehypertension a risk factor for the development of type 2 diabetes?

Authors:  David R Mullican; Carlos Lorenzo; Steven M Haffner
Journal:  Diabetes Care       Date:  2009-07-23       Impact factor: 17.152

10.  Dark chocolate or tomato extract for prehypertension: a randomised controlled trial.

Authors:  Karin Ried; Oliver R Frank; Nigel P Stocks
Journal:  BMC Complement Altern Med       Date:  2009-07-08       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.